WHO Expert Committee on Specifications for Pharmaceutical Preparations:thirty-ninth report.
Saved in:
Corporate Authors: | ; |
---|---|
Published: |
World Health Organization,
|
Publisher Address: | Geneva |
Publication Dates: | 2005. |
Literature type: | Book |
Language: | English |
Series: |
WHO technical report series ; 929 |
Subjects: | |
Carrier Form: | vii, 142 p.: ill. ; 24 cm. |
ISBN: | 9241209291 |
Index Number: | R9 |
CLC: |
R9-65 R95-532 |
Call Number: | R95-532/W927/2004 |
Contents: |
"WHO Expert Committee on Specifications for Pharmaceutical Preparations, Geneva, 25-29 October 2004"--P. v. Includes bibliographical references. This report discusses the monographs on antiretrovirals proposed for inclusion in The International Pharmacopoeia and specifications for radiopharmaceuticals, quality specifications for antituberculosis drugs and the revision of the monograph on artemisinin derivatives, as well as quality control of reference materials, good manufacturing practices, inspection, distribution and trade, and other aspects of quality assurance of pharmaceuticals, and regulatory issues. Several annexes include an amendment to good manufacturing practices: main principles regarding the requirement for the sampling of starting materials, guidelines on good manufacturing practices regarding water for pharmaceutical use, guidelines on the sampling of pharmaceutical products, and draft guidelines for registration of fixed-dose combination medicinal products. |